Grifols SA ADR (GRFS)

6.91
-0.12(-1.71%)
After Hours
6.91
0.00(0.00%)
- Real-time Data
  • Volume:
    1,985,832
  • Day's Range:
    6.57 - 7.17
  • 52 wk Range:
    6.57 - 15.90
Trading near 52-week Low

Grifols ADR has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

GRFS Overview

Prev. Close
7.03
Day's Range
6.57-7.17
Revenue
10.41B
Open
7.02
52 wk Range
6.57-15.9
EPS
0.088
Volume
1,985,832
Market Cap
5.91B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
996,459
P/E Ratio
21.36
Beta
0.136
1-Year Change
-54.02%
Shares Outstanding
678,910,694
Next Earnings Date
Nov 04, 2022
What is your sentiment on Grifols ADR?
or
Market is currently closed. Voting is open during market hours.

Grifols SA ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Grifols SA ADR Analysis

Grifols SA ADR Company Profile

Grifols SA ADR Company Profile

Employees
23245

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Read More

Analyst Price Target

Average13.30 (+92.47% Upside)
High16.2
Low10.4
Price6.91
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell
  • stubborn stock
    0
    • Damn missed it by inches
      0